Henry Schein (NSDQ:HSIC) said today that it agreed to buy a majority stake in Brazil’s Dental Cremer, which distributes dental supplies and equipment, for an undisclosed amount. Blumenau-based Dental Cremer posted sales of roughly $70 million last year and employs about 530 workers, Schein said. “As Brazil’s dental market grows, fueled by an aging population and an expanding […]
Mergers & Acquisitions
Halma pays $140m for sensor maker CenTrak
(Reuters) — Healthcare devices maker Halma said it bought CenTrak, a privately owned maker of sensors, for about $140 million (£95.9 million), expanding its footprint in the U.S. healthcare market. Amersham, England-based Halma, which makes products such as water quality test kits and smoke detector sensors, said the deal, funded using its existing cash and debt […]
Endologix, TriVascular Technologies close $211m merger
Endologix (NSDQ:ELGX) and TriVascular Technologies (NSDQ:TRIV) said yesterday that they closed their $221 million merger, uniting 2 of the stent graft market’s smaller players. Both companies makes devices for treating abdominal aortic aneurysms; Irvine, Calif.-based Endologix makes 2 lines of stent grants, the Nellix and AFX devices, while Santa Rosa, Calif.-based TriVascular makes the Ovation stent graft. “The completion […]
CryoLife deals Hero graft to Merit Medical for $19m
CryoLife Inc. (NYSE:CRY) said today that it dealt its Hero hemodialysis access graft to Merit Medical (NSDQ:MMSI) for $18.5 million in cash. The Hero graft put up $7.5 million in sales for CryoLife last year, the Atlanta-based company said. The deal calls for CryoLife to continue manufacturing the device for up to 6 months, when Salt Lake […]
Toshiba bails on non-imaging healthcare biz
Toshiba (TYO:6502) said today that it’s planning to ditch or transfer all of its healthcare business that’s not a part of Toshiba Medical Systems, its imaging division, and forecast higher losses for the rest of the year. A bidding war for Toshiba Medical is heating up among a slew of private equity players and rival corporations, as the Japanese industrial […]
Cantel Medical buys NAMSA’s sterility assurance biz for $14m
Cantel Medical (NYSE:CMN) and North American Science Associates said they agreed to a $13.5 million cash deal for NAMSA’s sterility assurance business, which Cantel said it plans to fold into its Crosstex division. The NAMSA operation, which posted sales of %5.7 million last year, makes biological and chemical indicators designed to monitor the effectiveness of sterilization procedures. […]
Insulet deals Neighborhood Diabetes biz to Liberty Med for $5m
Insulet (NSDQ:PODD) said today it’s selling its Neighborhood Diabetes supplies biz to mail order medical supply company Liberty Medical for $5 million in cash, $58 million less than the company paid for it in 2011. The Billerica, Mass.-based company said it expects the sale to close sometime in the 1st quarter, and said it expects the […]
An acquisition a day keeps the doctor away: Abbott acquires Kalila Medical
Abbott (NYSE:ABT) said today that it acquired Kalila Medical and its Vado steerable sheath for an undisclosed amount. It’s the 2nd buyout in as many days for the Abbott Park, Ill.-based healthcare giant, which yesterday said it plans to pay $5.8 billion for point-of-care diagnostics maker Alere. Kalila, which is based in Campbell, Calif., won 510(k) clearance from […]
TE Connectivity picks up Creganna Medical for $895m
TE Connectivity (NYSE:TEL) said today that it agreed to pick up Irish medical device maker Creganna Medical for $895 million in cash. Cregganna, which is owned by private equity shop Permira Funds, posted sales of $250 million last year, Schaffhausen, Switzerland-based TE Connectivity said. “We expect our interventional sales post Creganna will increase to well […]
Amgen, Unilife extend talks on exclusivity deal
Unilife (NSDQ:UNIS) and Amgen (NSDQ:AMGN) are giving themselves to the end of the week to come to an agreement on whether their deal for Unilife’s wearable injector technology will be exclusive to Amgen. UNIS shares jumped last month after the companies revealed the initial deal, which called for a non-refundable $15 million deposit from Amgen, which will use Unilife’s […]
Medtech M&A madness: Abbott to pay nearly $6B for Alere
Abbott (NYSE:ABT) said today that it agreed to put nearly $6 billion on the table for diagnostics giant Alere (NYSE:ALR), saying it aims to become the leading point-of-care testing provider with annual sales of more than $7 billion. Abbott Park, Ill.-based Abbott said it agreed to pay $56 per share for Waltham, Mass.-based Alere, marking a roughly […]